Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 168, Issue 3, 2002, Pages 1457-1465

  Sun, Yonglian ^a   Lin, Xiaoqi ^a   Chen, Helen M ^a   Wu, Qiang ^a   Subudhi, Sumit K ^a   Chen, Lieping ^a   Fu, Yang Xin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; MONOCLONAL ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0036467421     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.3.1457     Document Type: Article

References (38)

1. CD28/B7 system of T cell costimulation
2. Differential T cell costimulatory requirements in CD28-deficient mice
3. Absence of B7-dependent responses in CD28-deficient mice
4. Costimulation of CD28 T lymphocytes by 4-1BB ligand
5. Inducible T cell antigen 4-1BB: Analysis of expression and function
6. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies
7. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor
8. 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-μ-primed splenic B cells
9. Molecular and biological characterization of human 4-1BB and its ligand
10. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP
11. Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells
12. - T cells
13. CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand
14. Role of 4-1BB in immune responses
15. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
16. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
17. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 co-stimulatory pathway
18. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal
19. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus
20. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses
21. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand
22. Ligation of 4-1BB (CDw 137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients
23. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy
24. Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy
25. Genetic and molecular aspects of demyelination
26. Immunopathogenesis of multiple sclerosis
27. + T cells in the pathogenesis of organ-specific autoimmune diseases
28. Pathogenesis and immunotherapy of autoimmune diseases
29. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations
30. Real-time quantitative PCR
31. Quantification of murine cytokine mRNAs using real-time quantitative reverse transcriptase PCR
32. low thymocytes in vivo
33. Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo
34. Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen
35. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody
36. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death
37. + T cells in the absence of tumor-antigen vaccination
38. Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process